Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 1, 2008, Pages 64-71

  Leb, Victoria M ^a   Jahn Schmid, Beatrice ^b   Schmetterer, Klaus G ^a   Kueng, Hans J ^a   Haiderer, Daniela ^a   Neunkirchner, Alina ^a   Fischer, Gottfried F ^b   Nissler, Karl ^c   Hartl, Arnulf ^d   Thalhamer, Josef ^e   Bohle, Barbara ^b   Seed, Brian ^f   Pickl, Winfried F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITY OF SALZBURG   (Austria)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Art v 1; artificial antigen presenting cell; human T cell receptor; mugwort pollinosis; T cell receptor transgenic T cells; Type I allergy

Indexed keywords

ALLERGEN; ART V 1 ALLERGEN; HLA DR ANTIGEN; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN DERIVATIVE; T LYMPHOCYTE RECEPTOR; TETRAMER; TRAJ45 PROTEIN; TRAV17 PROTEIN; TRBD1 PROTEIN; TRBJ2 7 PROTEIN; TRBV18 PROTEIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BETA CHAIN; CELL ACTIVATION; CELL CLONING; CELL STIMULATION; EPSTEIN BARR VIRUS; FUNCTIONAL ASSESSMENT; GENE AMPLIFICATION; GENETIC ANALYSIS; HELPER CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR CLONING; MULTIGENE FAMILY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ALLERGENS; AMINO ACID SEQUENCE; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; CLONING, MOLECULAR; HLA-A ANTIGENS; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 38149082525     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.10.006     Document Type: Article

References (43)

1. Larche M., Akdis C.A., and Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6 (2006) 761-771
2. Akdis M., and Akdis C.A. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119 (2007) 780-791
3. Zinkernagel R.M., and Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248 (1974) 701-702
4. Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol 4 (2004) 675-687
5. Wang J.H., and Reinherz E.L. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol Immunol 38 (2002) 1039-1049
6. Hayes S.M., Shores E.W., and Love P.E. An architectural perspective on signaling by the pre-, alphabeta and gammadelta T cell receptors. Immunol Rev 191 (2003) 28-37
7. Dembic Z., Haas W., Weiss S., McCubrey J., Kiefer H., von Boehmer H., et al. Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature 320 (1986) 232-238
8. Clay T.M., Custer M.C., Sachs J., Hwu P., Rosenberg S.A., and Nishimura M.I. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 163 (1999) 507-513
9. Heemskerk M.H., Hoogeboom M., Hagedoorn R., Kester M.G., Willemze R., and Falkenburg J.H. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. J Exp Med 199 (2004) 885-894
10. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., and Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72 (1993) 551-560
11. Katz J.D., Wang B., Haskins K., Benoist C., and Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74 (1993) 1089-1100
12. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., et al. Ablation of "tolerance" induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 (1991) 305-317
13. Pircher H., Burki K., Lang R., Hengartner H., and Zinkernagel R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342 (1989) 559-561
14. von Boehmer H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 8 (1990) 531-556
15. Beyer K., Hausler T., Kircher M., Nickel R., Wahn U., and Renz H. Specific V beta T cell subsets are associated with cat and birch pollen allergy in humans. J Immunol 162 (1999) 1186-1191
16. Breiteneder H., Scheiner O., Hajek R., Hulla W., Huttinger R., Fischer G., et al. Diversity of TCRAV and TCRBV sequences used by human T-cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen. Immunogenetics 42 (1995) 53-58
17. Joost van Neerven R., van t'Hof W., Ringrose J.H., Jansen H.M., Aalberse R.C., Wierenga E.A., et al. T cell epitopes of house dust mite major allergen Der p II. J Immunol 151 (1993) 2326-2335
18. Kircher M.F., Haeusler T., Nickel R., Lamb J.R., Renz H., and Beyer K. Vbeta18.1(+) and V(alpha)2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects. J Allergy Clin Immunol 109 (2002) 517-523
19. Wedderburn L.R., O'Hehir R.E., Hewitt C.R., Lamb J.R., and Owen M.J. In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci U S A 90 (1993) 8214-8218
20. Himly M., Jahn-Schmid B., Dedic A., Kelemen P., Wopfner N., Altmann F., et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. FASEB J 17 (2003) 106-108
21. Jahn-Schmid B., Fischer G.F., Bohle B., Fae I., Gadermaier G., Dedic A., et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1*01. J Allergy Clin Immunol 115 (2005) 399-404
22. Jahn-Schmid B., Kelemen P., Himly M., Bohle B., Fischer G., Ferreira F., et al. The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 169 (2002) 6005-6011
23. Derdak S.V., Kueng H.J., Leb V.M., Neunkirchner A., Schmetterer K.G., Bielek E., et al. Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules. Proc Natl Acad Sci U S A 103 (2006) 13144-13149
24. van Bergen J., Schoenberger S.P., Verreck F., Amons R., Offringa R., and Koning F. Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc Natl Acad Sci U S A 94 (1997) 7499-7502
25. Bauer R., Himly M., Dedic A., Ferreira F., Thalhamer J., and Hartl A. Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen. Allergy 58 (2003) 1003-1010
26. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90 (1993) 8392-8396
27. Ory D.S., Neugeboren B.A., and Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 93 (1996) 11400-11406
28. Nissler K., Kreusch S., Rommerskirch W., Strubel W., Weber E., and Wiederanders B. Sorting of non-glycosylated human procathepsin S in mammalian cells. Biol Chem 379 (1998) 219-224
29. Lefranc M.P., Giudicelli V., Kaas Q., Duprat E., Jabado-Michaloud J., Scaviner D., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 33 (2005) D593-D597
30. Lamb J.R., Eckels D.D., Lake P., Woody J.N., and Green N. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature 300 (1982) 66-69
31. van Neerven R.J., Ebner C., Yssel H., Kapsenberg M.L., and Lamb J.R. T-cell responses to allergens: epitope-specificity and clinical relevance. Immunol Today 17 (1996) 526-532
32. Bohle B. T-cell epitopes of food allergens. Clin Rev Allergy Immunol 30 (2006) 97-108
33. Valenta R., and Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 119 (2007) 826-830
34. Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 119 (2007) 906-909
35. Niederberger V., Horak F., Vrtala S., Spitzauer S., Krauth M.T., Valent P., et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A 101 suppl 2 (2004) 14677-14682
36. Bohle B., Breitwieser A., Zwolfer B., Jahn-Schmid B., Sara M., Sleytr U.B., et al. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. J Immunol 172 (2004) 6642-6648
37. Gafvelin G., Parmley S., Neimert-Andersson T., Blank U., Eriksson T.L., van Hage M., et al. Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens. J Biol Chem 282 (2007) 3778-3787
38. Metz-Favre C., Linhart B., Focke-Tejkl M., Purohit A., de Blay F., Valenta R., et al. Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule. J Allergy Clin Immunol 120 (2007) 315-321
39. Hsu B.L., Evavold B.D., and Allen P.M. Modulation of T cell development by an endogenous altered peptide ligand. J Exp Med 181 (1995) 805-810
40. Han B., Serra P., Amrani A., Yamanouchi J., Maree A.F., Edelstein-Keshet L., et al. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 11 (2005) 645-652
41. Kappos L., Comi G., Panitch H., Oger J., Antel J., Conlon P., et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med 6 (2000) 1176-1182
42. Kinnunen T., Jutila K., Kwok W.W., Rytkonen-Nissinen M., Immonen A., Saarelainen S., et al. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy. J Allergy Clin Immunol 119 (2007) 965-972
43. Peterson A., and Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54 (1988) 65-72